6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party

Publisher： Karger

E-ISSN： 1421-9867|73|1|25-31

ISSN： 0012-2823

Source： Digestion, Vol.73, Iss.1, 2009-01, pp. : 25-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease

By Qasim Asghar McDonald Sharon Sebastian Shaji McLoughlin Ramona Buckley Martin O'Connor Humphrey O'Morain Colm

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 2, 2007-01 ,pp. : 194-199

Informa Healthcare

Access to resources Recommend Favorite

Probiotics for Inflammatory Bowel Disease: A Critical Appraisal

Digestive Diseases, Vol. 27, Iss. 1, 2010-03 ,pp. : 111-114

Karger

Access to resources Recommend Favorite

Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration

By Kochi Shuji Matsumoto Takayuki Esaki Motohiro Jo Yukihiko Iida Mitsuo

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 5, 2010-05 ,pp. : 608-614

Informa Healthcare

Access to resources Recommend Favorite

Saliva Interleukin-6 in patients with inflammatory bowel disease

By Aleksandra Nielsen Aneta Nederby Nielsen Jens Schmedes Anne Brandslund Ivan Hey Henrik

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 12, 2005-12 ,pp. : 1444-1448

Informa Healthcare

Access to resources Recommend Favorite

Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease

By Sipponen Taina Turunen Ulla Lautenschlager Irmeli Nieminen Urpo Arola Johanna Halme Leena

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 11, 2011-11 ,pp. : 1324-1333

Informa Healthcare

Access to resources Recommend Favorite